Skip to main content
. 2015 Jan 1;23(1):71–76. doi: 10.4062/biomolther.2014.042

Fig. 1.

Fig. 1.

PPARγ ligands inhibit Th17 cells differentiation. (A) Naïve CD4+ T cells were purified and differentiated into Th17 cells with or without 25 μM of ciglitazone, rosiglitazone, and troglitazone. After 7 days, IL-17 producing CD4+ cells were analyzed using FACS. (B) Data from IL-17-producing cells with various concentrations of PPARγ ligand are indicated. One-way ANOVA was used for statistical analysis (p<0.01).